Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sarcoma, Ewing × Phenytoin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 2 Leukemia 2 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Sarcoma 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1

Interventions

Cyclophosphamide 21 Temozolomide 19 Irinotecan 16 Vincristine 14 Doxorubicin 11 Topotecan 10 Melphalan 10 Etoposide 9 Busulfan 8 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Magnetic Resonance Spectroscopy 6 Filgrastim 6 cabozantinib 5 X-Rays 5 Sirolimus 5 Drug Therapy 5 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 fludarabine phosphate 4 fludarabine 4 Trabectedin 4 Specimen Handling 4 Phantoms, Imaging 4 Gemcitabine 4 regorafenib 3 irinotecan sucrosofate 3 abemaciclib 3 Zoledronic Acid 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03778996 2025-02-24

HopES

Sarcoma Oncology Research Center, LLC

Phase 2 Active not recruiting

Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡